{
    "nctId": "NCT06499168",
    "briefTitle": "Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer",
    "officialTitle": "CD10 as a Prognostic and Predictive Factor to Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Locally Advanced Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "The response to neoadjuvant chemotherapy in locally advanced breast cancer in relation to CD10 expression",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients above 18 years\n* Pathologically proven breast carcinoma\n* Locally advanced breast cancer\n\nExclusion Criteria:\n\n* Patients below 18 years.\n* Patients with metastatic disease\n* Patients with second primary cancer\n* Patients ineligible for chemotherapy",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}